Toronto Rehabilitation Institute
55
6
7
33
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
12.7%
7 terminated/withdrawn out of 55 trials
82.5%
-4.0% vs industry average
16%
9 trials in Phase 3/4
15%
5 of 33 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (55)
Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk
Role: collaborator
Cardio-Oncology Rehabilitation Exercise
Role: collaborator
Behaviour Change for Cancer Survivors Trial
Role: collaborator
PROPEL Randomized Trial
Role: lead
AquaReBal - Aquatic Reactive Balance Training for Older Adults
Role: collaborator
Reactive Balance Training and Fitness
Role: lead
Determining the Optimal Dose of Reactive Balance Training After Stroke
Role: lead
Optimal Intensity of Reactive Balance Training Post-stroke
Role: lead
Optimal Intensity of Reactive Balance Training for Healthy Older Adults
Role: lead
Online Memory Intervention for Individuals with Traumatic Brain Injury
Role: lead
Self-Management Interventions for Long COVID-19
Role: lead
Brain MRI for Knee OA
Role: lead
Bio-signal Telemonitoring Using Electronic Textiles in a Pediatric Population
Role: collaborator
Oropharyngeal Exercises and Post-Stroke Obstructive Sleep Apnea
Role: collaborator
Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure
Role: lead
Nurse Practitioner Led Implementation of Team Huddles in Long-Term Care Homes
Role: lead
Restoration of Upper Limb Function in Individuals With Sub-Acute Spinal Cord Injury
Role: lead
Quantitative Ultrasound Response of Capsaicin
Role: lead
DBS of PPN to Improve Walking in Chronic SCI Patients
Role: collaborator
Lifestyle, Exercise and Diet: The LEAD Study
Role: collaborator